Catalyst Wire Dossier Catalyst Wire Dossier

TQC3302 inhalation spray

TQC3302 · Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQC3302 inhalation spray, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects [Phase 1]

See pricing